IMU 3.53% 8.2¢ imugene limited

I have also been following rock lobster (real patient comments...

  1. 3,102 Posts.
    lightbulb Created with Sketch. 754
    I have also been following rock lobster (real patient comments receiving treatment from March this year)
    I know everyone wanted an update from the trials at the recent conference, given the attatched statements regarding our complete response patient it has me thinking are Imugene timing the data cut release around a time line that would increase their chances of significant reductions in tumour size
    https://hotcopper.com.au/data/attachments/6098/6098063-ee327115540c14bdddd23c9d8d30aa40.jpg
    question is does imugene request data at their own discretion, meaning can they hold off releasing data by simply not requesting it, the reason I ask is rock lobster mentioned our complete response patients tumour size initially grew 50% before reducing to zero , Imugene has also seen initial size increases in other patients before shrinking, could they be holding off requesting data until when they think the possible increase in tumour sizes in our patients are passed the early angry growth stage
    makes sense tumours become very active trying to survive and grow when infected by our virus

    I think imugene need to announce when they are likely to have new information ie at what conference could we expect the data we need








    https://hotcopper.com.au/data/attachments/6098/6098055-6969d64b270fd06678e8f09fdfc9f8ee.jpg
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
-0.003(3.53%)
Mkt cap ! $600.2M
Open High Low Value Volume
8.5¢ 8.6¢ 8.2¢ $1.246M 14.84M

Buyers (Bids)

No. Vol. Price($)
4 446526 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 535664 2
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
8.2¢
  Change
-0.003 ( 2.38 %)
Open High Low Volume
8.6¢ 8.6¢ 8.2¢ 4518456
Last updated 15.57pm 03/05/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.